Rate My Professor Wai Lim

Professor Wai Lim is a Professor of Renal Medicine in the Nutrition & Health Innovation Research Institute within the School of Medical and Health Sciences at Edith Cowan University. He is also the Medical Director of Kidney Transplantation and Head of the Department of Renal Medicine and Transplantation at Sir Charles Gairdner Hospital, as well as Clinical Professor of Medicine at the University of Western Australia. He completed his Fellowship of the Royal Australasian College of Physicians training in Nephrology in 2003 and was awarded his PhD in 2006 by the University of Adelaide. Professor Lim holds qualifications including MBBS, PhD, and FRACP.

His research focuses on epidemiology and kidney transplantation to improve allocation and health outcomes; immunology profiles and transplant outcomes for personalised risk scoring; and epidemiology and clinical nephrology examining nutrition impacts, biomarkers, and cardiovascular disease in chronic kidney disease and transplant patients. Key areas include kidney transplantation, chronic kidney disease, cardiovascular disease, transplant immunology, and cancer. He has received over $12 million in funding, including six NHMRC grants and two Career Development Fellowships. His internationally recognised transplantation research informs clinical decisions, donor kidney allocation policies, and chronic kidney disease patient selection. He co-leads a Western Australian Indigenous taskforce engaging leaders to enhance kidney transplant education and access for Indigenous Australians. Professor Lim has held roles such as member of the National Renal Transplant Advisory Committee, Co-Chair of the TSANZ Scientific Program and Education Committee, Chair of the Scientific Review Ethics Subcommittee at Sir Charles Gairdner Hospital, and editorial positions including Associate Editor for Transplant International, Nephrology, and Frontiers in Immunology. Awards include the 2017 Kidney Health Australia Finalist Award, 2016 Mark Cocks Award and Kidney Health Australia Best Clinical Science Award from TSANZ, and earlier recognitions from 2015, 2013, and 2005. Key publications include 'Sex Disparity and the Uptake of Home Dialysis following Kidney Transplant Failure' (2025, American Journal of Nephrology), 'Management of Atypical Haemolytic Uraemic Syndrome With Triggers' (2025, Nephrology), 'High-Sensitivity Cardiac Troponin I and Frailty' (2026, Journal of Gerontology Series A), and 'Outcomes of Solid Organ Transplant Recipients with Advanced Cancers Receiving Immune Checkpoint Inhibitors' (2025, JAMA Oncology).